A phase 1, randomized, placebo-controlled, single-and multiple-dose, double-blind study to evaluate the pharmacokinetics and safety of rimegepant orally disintegrating tablets 75 mg in healthy Chinese adults

被引：0
作者：
Li, Y. [1 ]
Bertz, R. [2 ]
Goodrich, R.
机构：
[1] Capital Med Univ, Beijing Shijitan Hosp, Beijing, Peoples R China
[2] Biohaven Pharmaceut, New Haven, CT USA
来源：
HEADACHE | 2022年 / 62卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
LB-P-19
引用
收藏
页码：922 / 922
页数：1
相关论文
共 50 条
  • [41] Phase 1, Randomized, Double-Blind, Placebo-Controlled Studies on the Safety, Tolerability, and Pharmacokinetics of Naldemedine in Healthy Volunteers
    Fukumura, Kazuya
    Yokota, Takaaki
    Baba, Yuko
    Ferreira, Juan Camilo Arjona
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (05): : 474 - 483
  • [42] Efficacy, safety, and tolerability of rimegepant orally disintegrating tablet for the acute treatment of migraine: a randomised, phase 3, double-blind, placebo-controlled trial
    Croop, Robert
    Goadsby, Peter J.
    Stock, David A.
    Conway, Charles M.
    Forshaw, Micaela
    Stock, Elyse G.
    Coric, Vladimir
    Lipton, Richard B.
    [J]. LANCET, 2019, 394 (10200) : 737 - 745
  • [43] Human Safety and Pharmacokinetics Study of Orally Administered Icariin: Randomized, Double-Blind, Placebo-Controlled Trial
    Brown, E. Sherwood
    Bice, Collette
    Putnam, William C.
    Leff, Richard
    Kulikova, Alexandra
    Nakamura, Alyson
    Ivleva, Elena I.
    Enkevort, Erin Van
    Holmes, Traci
    Miingi, Nyokabi
    [J]. NATURAL PRODUCT COMMUNICATIONS, 2019, 14 (06)
  • [44] PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE- AND MULTIPLE-ASCENDING DOSE STUDY OF THE SAFETY, TOLERABILITY AND PHARMACOKINETICS OF THE ASK1 INHIBITOR SRT-015 IN HEALTHY ADULTS
    Burge, Daniel J.
    Elias, Kathleen
    Plonowski, Artur
    Porter, Terence
    McDonnell, Neil
    [J]. HEPATOLOGY, 2022, 76 : S97 - S97
  • [45] A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Ascending Single Dose Study to Evaluate the Safety, Tolerability and Pharmacodynamics of AMG145
    Dias, Clapton
    Shaywitz, Adam
    Smith, Brian
    Emery, Maurice
    Bing, Gao
    Gibbs, John
    Wishner, Bill
    Stolman, Dina
    Crispino, Caroline
    Crispino, Caroline
    Cook, Blaire
    Colbert, Alex
    Retter, Marc
    Xu, Ren
    Matson, Mark
    [J]. CIRCULATION, 2011, 124 (21)
  • [46] A RANDOMIZED, SINGLE-CENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTIPLE-DOSE, PHASE 1 STUDY TO EVALUATE THE SAFETY, PHARMACOKINETICS (PK), AND PHARMACODYNAMICS (PD) OF TAK-272 IN HEALTHY ADULT NON-ELDERLY AND ELDERLY MALE SUBJECTS
    Matsuno, K.
    Tanaka, S.
    Hashimoto, T.
    Nakamichi, H.
    Komura, E.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 265 - +
  • [47] PHARMACOKINETICS, SAFETY AND TOLERABILITY OF SINGLE- AND MULTIPLE-DOSE ONCE-DAILY BARICITINIB IN CHINESE HEALTHY VOLUNTEERS - A RANDOMIZED PLACEBO-CONTROLLED STUDY
    Zhao, Xia
    Payne, Christopher
    Wang, Feng
    Cui, Yiming
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 378 - 378
  • [48] Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase I study
    Huang, Kai
    Ding, Ying
    Que, Linling
    Chu, Nannan
    Shi, Yunfei
    Qian, Zhenzhong
    Qin, Wei
    Chen, Yuanxin
    Gu, Xianghong
    Wang, Jiakun
    Zhang, Zhiwei
    Xu, Jianguo
    He, Qing
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [49] A single-center, randomized, placebo-controlled, double-blind study to evaluate the safety, tolerability, and pharmacokinetics of multiple-ascending doses of pridopidine in healthy volunteers
    Osterberg, O.
    Ivkovic, J.
    Sundgreen, C.
    Muglia, P.
    Prang, A.
    Darpo, B.
    [J]. NEUROTHERAPEUTICS, 2013, 10 (01) : 175 - 175
  • [50] Efficacy, Safety, and Tolerability of Rimegepant 75 mg Orally Dissolving Tablet for the Acute Treatment of Migraine: Results from a Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial, Study 303
    Lipton, Richard B.
    Coric, Vladimir
    Stock, David A.
    Gosden, Ralph
    Forshaw, Micaela
    Croop, Robert
    Conway, Charlie
    [J]. CEPHALALGIA, 2019, 39 : 7 - 8
12345